These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 19663836
1. Extracorporeal photopheresis: what is it and when should it be used? Scarisbrick J. Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836 [Abstract] [Full Text] [Related]
2. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S, Photopheresis Expert Group. Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274 [Abstract] [Full Text] [Related]
3. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R, British Photodermatology Group, UK Skin Lymphoma Group. Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088 [Abstract] [Full Text] [Related]
4. Extracorporeal photophoresis: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2006 Jan; 6(6):1-82. PubMed ID: 23074497 [Abstract] [Full Text] [Related]
7. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications. Chiesa-Fuxench ZC, González-Chávez J. P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172 [Abstract] [Full Text] [Related]
12. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases]. Kofoed K, Schiødt I, Gniadecki R. Ugeskr Laeger; 2011 Jun 27; 173(26):1869-74. PubMed ID: 21712008 [Abstract] [Full Text] [Related]
13. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P. Bone Marrow Transplant; 2003 Mar 27; 31(6):459-65. PubMed ID: 12665841 [Abstract] [Full Text] [Related]
14. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Hackstein H, Misterek J, Nockher A, Reiter A, Bein G, Woessmann W. Transfusion; 2009 Nov 27; 49(11):2366-73. PubMed ID: 19903292 [Abstract] [Full Text] [Related]
17. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Fimiani M, Di Renzo M, Rubegni P. Br J Dermatol; 2004 Jun 27; 150(6):1055-60. PubMed ID: 15214889 [Abstract] [Full Text] [Related]
18. Extracorporeal photopheresis: technique, established and novel indications. Marques MB, Adamski J. J Clin Apher; 2014 Aug 27; 29(4):228-34. PubMed ID: 24828404 [Abstract] [Full Text] [Related]
19. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. Bladon J, Taylor P. J Clin Apher; 2002 Aug 27; 17(4):177-82. PubMed ID: 12494410 [Abstract] [Full Text] [Related]
20. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada. Lagacé F, Netchiporouk E, Turchin I, Gulliver W, Dutz J, Kirchhof MG, Popradi P, Gniadecki R, Lynde C, Litvinov IV. Skin Therapy Lett; 2022 Sep 27; 27(5):1-6. PubMed ID: 36469458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]